NCHR Report: Breast Implant Illness — What’s the Evidence?

The National Center for Health Research report on Breast Implant Illness (BII) reviews decades of research before and after the term Breast Implant Illness became popular. Whether referred to as autoimmune symptoms, neurological symptoms, connective tissue disease, neurological symptoms, or BII, we find clear evidence of an increase in symptoms associated with breast implants, compared to women who do not have breast implants. We provide specific examples of how research that dismissed the evidence was poorly designed, often focusing on specific autoimmune diseases, only evaluated hospitalization as evidence of disease, studied women who had breast implants for a short period of time, or had other major flaws.

Read More »

Patients Must Be Warned of Breast Implant Risks, F.D.A. Says

The New York Times, October 27, 2021: The FDA has placed black box warnings on breast implant packaging and told manufacturers to sell the implants only to health providers who review the potential risks with patients before surgery, and tell them the risks are even higher for breast cancer patients. The National Center for Health Research asks who will enforce that?

Read More »

What You Need to Know About Breast Implants

Research clearly shows that implants are associated with significant health, cosmetic, and economic risks within the first few years and these risks increase over time. Unfortunately, long-term risks remain unknown because of a lack of careful scientific studies. FDA has required implant manufacturers to conduct additional research to determine why implants break, how long they can be expected to last, and what the longer-term health consequences of broken and leaking breast implants might be. Those studies, however, have not yet been made public.

Read More »